Duc-Hanh Thi Nguyen

Title: Duc-Hanh Thi Nguyen: Innovator in Antibody Development

Introduction

Duc-Hanh Thi Nguyen is a prominent inventor based in Sylmar, CA (US). He has made significant contributions to the field of biotechnology, particularly in the development of optimized antibodies. With a total of 6 patents to his name, Nguyen is recognized for his innovative approaches to antibody design.

Latest Patents

Nguyen's latest patents include groundbreaking work on optimized antibodies that target HM1.24. The present disclosure describes antibodies that target HM1.24, featuring specific CDR, variable, or full-length sequences. These antibodies have modifications relative to the parent antibody, which alter affinity to an FcγR or modify effector function compared to the parent antibody. Additionally, nucleic acids encoding these antibodies and methods of using them are also disclosed.

Career Highlights

Nguyen is currently employed at Xencor, Inc., where he continues to push the boundaries of antibody research. His work has been instrumental in advancing therapeutic options for various diseases. His innovative spirit and dedication to research have earned him recognition in the scientific community.

Collaborations

Some of Nguyen's notable coworkers include Matthew J Bernett and John R Desjarlais. Their collaborative efforts contribute to the success of projects at Xencor, Inc., enhancing the development of novel therapeutic antibodies.

Conclusion

Duc-Hanh Thi Nguyen is a key figure in the field of antibody innovation, with a strong portfolio of patents and a commitment to advancing biotechnology. His work continues to impact the development of targeted therapies, showcasing the importance of innovation in healthcare.